Clinical trials on AL Amyloidosis

  • CT-EU-00117859

    Isatuximab Plus Pomalidomide and Dexamethasone for AL Amyloidosis

    This clinical trial is focused on patients with AL Amyloidosis who have not achieved a very good partial response or better following previous therapies. The trial investigates the efficacy of combining Isatuximab, Pomalidomide, and Dexamethasone. The aim is to see if this drug combination can significantly reduce the levels of misfolded proteins in the blood, which are characteristic of this disease, thereby improving the condition and potentially prolonging life. This study seeks to offer a new potential treatment option for those who have limited responses to existing therapies.

    • Isatuximab